Antiglobulin control cells
US4326027A · kind A · utility
2Cited by
5References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 28, 1978 |
| Grant date | Apr 20, 1982 |
| Priority date | — |
| Expiry date | Mar 28, 1998 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/967
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Antiglobulin control cells are disclosed wherein reagent human red blood cells are coated with univalent antibody fragments. These control cells provide a high degree of specifity in determining the presence of active anti-human sera, which specifity is lacking in conventional Coombs control cells. The evaluation results of the reactivity tests may be performed in the present manner, but the positive hemagglutination provides assurance of anti-human sera activity as opposed to other agglutinating activity, such as protein that might be present.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.